Globus Medical (GMED) PT Raised to $85 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $78.68 --0%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 2 | New: 31
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 2 | New: 31
Join SI Premium – FREE
BTIG analyst Ryan Zimmerman raised the price target on Globus Medical (NYSE: GMED) to $85.00 (from $83.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi Downgrades Nick Scali Limited (NCK:AU) to Sell
- DNB ASA (DNB:NO) (DNHBY) PT Raised to NOK286 at Barclays
- SAP (SAP:GR) (SAP) PT Raised to EUR250 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
